Mesa SchumacherJuly marks the 100-year anniversary of the Bacille Calmette-Guérin vaccine (BCG), still the only approved vaccine against TB. More than a dozen vaccines for TB are currently being tested in clinical trials: some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.
The Scientist reports on the discovery and shortcomings of BCG as well as on the new TB vaccines on the horizon:
*************************
More updates on TB research:
- EurekAlert!: Study links mental health with risk of TB
- Hackensack Meridian Health: Hackensack Meridian CDI scientists discover new TB treatment pathway
- European Molecular Biology Laboratory: Structural biology reveals new opportunities to combat TB
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.